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The diploid IR6 gene (ORF 67) of equine herpesvirus type 1 (EHV-1) is absent in the modified live EHV-1 vaccine strain
RacH and is present in a mutated form in the avirulent EHV-1 strains RacM24 and RacM36, such that the IR6 protein fails
to form the typical rod-like structures observed for wild-type EHV-1 RacL11. To assess the role of the IR6 protein in
EHV-1 replication and virulence, two recombinant RacH viruses, HIR6-1 and HIR6-2, that harbor a single copy of the wild-
type IR6 gene were engineered and characterized. It was shown that: (i) HIR6-1 or HIR6-2 virus encoded for an IR6 protein
that was capable of forming the rod-like structures typical of cells infected with the wild-type virulent virus strain RacL11.
(ii) Whereas the avirulent EHV-1 strains RacH and RacM36 are temperature-sensitive (in that virus replication at 407 versus
that at 377 was reduced by as much as 7,500-fold), the HIR6-1 and HIR6-2 viruses, like RacL11 virus, were capable of
significant replication at the elevated temperature. (iii) Electron microscopic analyses revealed that cells infected with the
HIR6-1 or HIR6-2 virus, like those infected with virulent RacL11 virus, produced and released comparable numbers of virus
particles at both 37 and 407. In cells infected with the RacH virus at 407, however, release of extracellular particles was
inhibited by greater than 90% and relatively few of the particles were enveloped. (iv) Infections of BALB/cA mice revealed
that both the HIR6-1 and HIR6-2 viruses, unlike the parent RacH virus, were as virulent as the wild-type RacL11 strain as
judged by the criteria of body weight loss, development of clinical signs of EHV-1 infection, virus titers in the lung, and
ability to cause viremia. These findings and those of our recent studies indicate that the IR6 protein is a major determinant
of EHV-1 virulence and that the IR6 protein may play a role in virus maturation and/or egress. q 1996 Academic Press, Inc.
INTRODUCTION ever, plaque-isolates of a medium Rac passage (185th
passage), RacM24 and RacM36, also proved to be aviru-Equine herpesvirus 1 (EHV-1) is a major pathogen of
lent for both the natural host and laboratory animals al-horses and causes late-time abortions and respiratory
though harboring one or both copies of the IR6 geneand neurological diseases (Allen and Bryans, 1986;
(Mayr et al., 1968; Hu¨bert et al., 1996). Previous studiesO’Callaghan et al., 1983). Although the genome of the
on the IR6 gene and the encoded polypeptide revealedinfectious agent, strain Ab4p, has been sequenced in its
that it is an abundantly produced very early phosphopro-entirety (Telford et al., 1992), the genes and gene prod-
tein of 31 to 33 kDa which is present throughout theucts involved in virulence of the virus are poorly under-
life cycle of EHV-1 strains KyA (O’Callaghan et al., 1994;stood. The only reports describing a correlation of ge-
Breeden et al., 1992; Colle and O’Callaghan, 1996), Ab4netic changes and loss of virulence concern the thymi-
(Sun et al., 1995), as well as RacL11, RacM24, anddine kinase gene (Cornick et al., 1990; Slater et al., 1993).
RacM36 (Osterrieder et al., 1996a). In cells infected withSeveral avirulent EHV-1 isolates are in use as modified
the avirulent isolates RacM24 and RacM36, however, thelive vaccines (MLV) to protect horses against EHV-1-
IR6 protein remains associated with membranes rathercaused disease (reviewed in Allen and Bryans, 1986).
than forming the rod-like structures typical of wild-typeOne of these, EHV-1 strain RacH, was attenuated by 256
EHV-1 strains. In addition, the IR6 protein of RacM24 andserial passages on porcine embryonic kidney cells (Mayr
RacM36 showed a decreased stability and was no longeret al., 1968). During its attenuation, several changes in
incorporated into viral nucleocapsids (Osterrieder et al.,the genome occurred, the most prominent being the dele-
1996a).tion of both copies of the IR6 gene (Meyer et al., 1992;
For an assessment of the virulence of individual EHV-Hu¨bert et al., 1996; Osterrieder et al., 1994, 1996a). How-
1 strains, two animal models, the Syrian hamster and the
Balb/cA mouse, have been developed (Mayr et al., 1968;1 To whom correspondence and reprint requests should be ad-
Stokes et al., 1989; Awan et al., 1990; Azmi and Field,dressed. Fax: /49-89-2180 2597. E-mail: klaus.osterrieder@lrz.uni-
muenchen.de. 1993; vanWoensel et al., 1995). It was shown that the
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virulence of individual strains in either of the models labeled after random priming with digoxigenin-11-dUTP
(Boehringer) and used as probes for Southern blot analy-correlated well with their behavior in the natural host
(Mayr et al., 1968; Inazu et al., 1993; Slater et al., 1993; sis.
vanWoensel et al., 1995; Hu¨bert et al., 1996; Matsumura
Purification of viral DNA and Southern blottinget al., 1996; Colle et al., 1996).
The rationale of the present study was to correlate the EHV-1 virions were purified by sucrose-density centrif-
genomic alterations of different EHV-1 strain Rac plaque- ugation (Osterrieder et al., 1996a), and proteins were
isolates with their phenotype (temperature-sensitivity) in hydrolyzed by incubation with Proteinase K (10 mg/ml)
cell culture and the loss of virulence in laboratory ani- for 3 hr at 567. Proteins were then extracted with phenol
mals. This question was addressed by constructing re- and chloroform, and viral DNA was precipitated from the
combinant RacH viruses which had one copy of gene IR6 aqueous phase using 4 M LiCl and ethanol. Genomic
inserted into their genomes. The RacH-IR6 recombinant DNA was cleaved with restriction enzymes BamHI or
viruses were compared to the original wild-type virus SalI and run on 0.8% agarose gels. DNA fragments were
(RacL11) and to the parental RacH virus concerning their transferred to positively charged nylon membranes
phenotype in cell culture and their virulence in a murine (HybondN/, Amersham) by vacuum blotting using 0.4 M
model of EHV-1 infection. NaOH (Reed and Mann, 1985). Sheets were incubated
with the labeled and heat-denatured probes suspended
MATERIALS AND METHODS in hybridization solution (Sambrook et al., 1989). Detec-
tion of hybrids with an anti-digoxigenin alkaline phospha-
Cells and viruses
tase-conjugate and subsequent color reaction with NBT
and X-phosphate were performed according to the manu-Plaque isolates of EHV-1 strain Rac (RacL11, RacM36,
facturer’s instructions (Boehringer).and RacH) were grown and titrated on the equine dermal
cell line Edmin337, equine embryonic lung cells (EEL)
Construction of recombinant viruses(kindly provided by J. A. Mumford, Newmarket, UK), or
Rk13 cells as described previously (Osterrieder et al., DNA (1 – 2 mg) of EHV-1 strain RacH was cotransfected
1996a). Single step growth characteristics of individual with 1 to 10 mg of pXU1A plasmid DNA into Rk13 cells at
viruses were determined by infection with 1 PFU per cell, 50– 60% confluency using the DOTAP reagent (Boeh-
incubation at 37 or 407 for 24 hr, and harvesting of cell- ringer) exactly as described previously (Osterrieder et al.,
associated as well as supernatant-released infectious 1996b). Three to five days after infection, when cytopathic
virions by two rounds of freeze-thawing. effects were maximal, supernatants were harvested,
The number of physical virus particles of the different plated onto Edmin337 cells, and incubated for 3 days
EHV-1 isolates released into the cell culture medium was under an agarose overlay. Individual virus plaques were
determined after incubation of infected cells (m.o.i.  1) picked, and progeny virus was tested for the presence
for 24 hr. Infected-cell supernatants (1 ml) were pre- of the IR6 gene by a PCR strategy that differentiates
cleared (8,000 g; 10 min, 47), the supernatant was layered isolates with an intact or deleted IR6 gene by giving
on a 30% sucrose cushion, and virions were ultracentri- amplification products of different sizes (Osterrieder et
fuged (SW60 rotor, 40,000 rpm, 1 hr, 47). Pelleted virions al., 1994). Individual recombinant viruses harboring an
were suspended in 100 ml phosphate-buffered saline intact IR6 gene were subjected to five consecutive
(PBS) and centrifuged (80,000 g; 20 min, 207) on copper rounds of plaque purification and analyzed by Southern
grids using an airfuge (Beckman). After centrifugation, blotting.
particles were fixed with 2% glutaraldehyde, counter-
stained with phosphotungstic acid, and counted in an Indirect immunofluorescence (IF) and cytofluorometry
electron microscope (Zeiss EM10C/CR) (Osterrieder et
Edmin337 cells seeded on coverslips were infectedal., 1995).
with different EHV-1 strains at 1 PFU per cell and fixed
at 12 hr p.i. with ice-cold acetone for 5 min. Cells wereReagents and plasmids
rehydrated with PBS and blocked with 2% fetal calf serum
(FCS) in PBS and then incubated with a monospecificThe BamHI-N fragment of the virulent EHV-1 plaque
isolate RacL11 (Hu¨bert et al., 1996) containing one copy anti-IR6 antiserum (O’Callaghan et al., 1994) for 30 min
at an 1:2000 dilution. After thorough washing with PBS,of the IR6 (ORF 67) gene was cloned into pTZ18R (Phar-
macia) using T4 ligase (Boehringer), and the recombinant coverslips were incubated with an anti-rabbit IgG FITC-
conjugate (Sigma) for 30 min. After two further washesplasmid was designated pXU1A (Fig. 1). Recombinant
plasmid p06 containing a 5.1-kbp PstI fragment of RacH in PBS, the coverslips were analyzed in a fluorescent
microscope. Analysis of infected cells by cytofluorometrywas generated and represents glycoprotein B (gB)-en-
coding sequences (Osterrieder et al., 1995) (Fig. 1). The was performed as described earlier (Osterrieder et al.,
1995, 1996b). Briefly, infected cells were harvested at 24fragments contained in the recombinant plasmids were
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FIG. 1. Schematic illustration of the genomic organization of EHV-1 strains RacL11, RacM24, RacM36, and RacH in the inverted repeat regions
of the genomes. Shown is the BamHI restriction map of RacL11. The 5.1-kp PstI-fragment of RacH that harbors sequences encoding glycoprotein
gB and is contained in plasmid p06 is shown. The RacL11 BamHI-N fragment contained in plasmid pXU1A is indicated. Restriction enzyme sites
are abbreviated: B, BamHI; P, PstI; S, SalI. The SalI site lacking in RacM24, RacM36, and RacH is marked by an asterisk. The IR6 and EUS1 genes
as well as mutated IR6 genes (mIR6) (RacM24, RacM36) are indicated, and deletions are marked by n.
hr p.i. and incubated for 30 min with anti-gB monoclonal gene (Hu¨bert et al., 1996; Osterrieder et al., 1996a), cells
were cotransfected with RacH genomic DNA and pXU1Aantibodies (mabs) 4B6 and Be/3F8 (Huemer et al., 1995;
plasmid DNA. Three to five days after the transfection,Osterrieder et al., 1995), or anti-glycoprotein M (gM) mab
supernatants were harvested and plated on Edmin33713B2 (Allen and Yeargan, 1987; Osterrieder et al., 1996b),
cells under an agarose overlay. Individual plaques werewhich was a generous gift of Dr. George P. Allen. After
picked and transferred to 24-well plates in which Ed-thorough washing with PBS, the cells were incubated
min337 cells were seeded. Progeny viruses were testedwith anti-mouse IgG FITC-conjugate (Sigma) for another
by a PCR assay of DNA of virions released in the cell30 min. After two final washing steps with PBS, cells
culture supernatants (Osterrieder et al., 1994), and somewere analyzed using the FACScan (Becton –Dickinson).
of the isolated viruses yielded amplification products ofAnimal experiments
495 bp, indicating the presence of an intact IR6 gene.
Three to four-week-old female BALB/cA mice (Charles However, all recombinants tested also contained a 310-
River) were divided into 5 groups of 10 animals each bp amplicon indicative of the deletion within the IR6 gene
and infected intranasally with EHV-1 isolates RacL11, (Osterrieder et al., 1994, 1996a). These results indicated
RacM36, RacH, or the IR6-recombinant RacH viruses that either a heterogeneous virus population was present
HIR6-1 or HIR6-2. Weights of individual mice were deter- or that only one copy of the IR6 gene was inserted into
mined from Day 0 (day of infection) to Day 8 p.i. On Days the RacH genome. Therefore, the progeny virus clones
1, 3, 5, and 8, two to three individual mice were sacrificed which gave the 495- and 310-bp amplification products
and lungs were collected. Lungs were homogenized in were subjected to five additional rounds of plaque purifi-
sea-sand and PBS, and virus was titrated on Edmin337 cation and again analyzed by PCR. Two of the plaque-
cells exactly as described earlier (Osterrieder et al., purified virions, HIR6-1 and HIR6-2, yielded amplification
1995). Mean body weights and mean virus titers of the products of 495 and 310 bp, indicating that one intact
mouse groups were compared by analysis of variance IR6 gene was inserted, and were chosen for further in-
and pairwise testing of significances was done ac- vestigation. To confirm the genotype of the IR6-recombi-
cording to Bonferroni (Holm, 1979). nant RacH viruses, Southern blot analyses were per-
formed. Viral DNA of RacL11, RacH, and the two recombi-RESULTS
nant viruses was prepared and cleaved with SalI or
Construction and characterization of RacH-IR6 BamHI. After BamHI digestion and subsequent Southern
recombinant viruses blotting, the labeled pXU1A probe hybridized to bands of
To insert the wild-type IR6 gene into the avirulent 4.9 and 4.5 kbp in RacL11 DNA preparations, whereas
bands of 4.0 and 3.6 kbp were detected in RacH DNAEHV-1 strain RacH which lacks both copies of the IR6
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which exhibited a rod-like appearance as seen for
RacL11 (data are shown for HIR6-1, Fig. 3), whereas the
RacM36-IR6 protein displayed an even or granular stain-
ing pattern in infected cells (Fig. 3). In RacH-infected
cells, no IR6 protein was detectable (Fig. 3).
From the above described experiments, it was con-
cluded that in both HIR6-1 and HIR6-2 one copy of the
IR6 gene was inserted into an RacH genomic background
and that these viruses expressed the wild-type form of
the IR6 protein in that the rod-like appearance of the
protein was detected in infected cells (Figs. 2 and 3).
Temperature-sensitivities of Rac isolates from
different cell culture passages and of the IR6-
recombinant viruses
Previous observations had suggested that RacH (256th
cell culture passage) and the medium (185th passage)
Rac passage derivatives RacM24 and RacM36 were im-
paired in growth at elevated incubation temperatures.
Therefore, either Edmin337 or EEL cells were infected
(m.o.i. 1) with RacH, RacM36, or RacL11 and incubated
for 24 hr either at 37 or 407. Virus preparations were
harvested and total infectious virus was titrated on Ed-
min337 cells at an incubation temperature of 377. A
marked reduction in virus titers (up to 7500-fold) was
FIG. 2. Southern blot analysis of BamHI- or SalI-cleaved DNA of the observed for virus progeny of the RacH or RacM36 virus
viruses HIR6-1 and HIR6-2 and comparison with wild-type RacL11 and produced at 407 as compared to the titers after incubation
the parental strain RacH. Viral DNA fragments generated by digestion at 377. In contrast, RacL11 virus titers were only slightly
of genomic DNAs with the respective restriction enzymes were sepa-
reduced (2.6- to 5.2-fold) at the elevated temperature ofrated by 0.8% agarose gel electrophoresis and transferred to a Nylon
407 (Table 1). When the growth characteristics of the IR6-membrane. Sheets were probed with labeled pXU1A (IR6 probe) or p06
(gB probe). The sizes of reactive fragments are indicated in kbp. recombinant viruses HIR6-1 and HIR6-2 were analyzed
at both temperatures, the titers obtained after a single
step growth at 407 were reduced by 8.4- to 14.9-fold whensamples. The reaction of 4.9- and 3.6-kbp fragments in
compared to those at 377. Thus, the titers of the IR6HIR6-1 and HIR6-2 revealed that in both IR6-recombinant
recombinant viruses exceeded that of the parental RacHviruses only one copy of the IR6 gene, located in the
virus by 310- to 390-fold at the nonpermissive tempera-BamHI-N fragment, was present (Fig. 2). The slightly
ture of 407 (Table 1) and were only slightly reduced asfaster migrating 3.6-kbp band of HIR6-1 and HIR6-2 as
compared to those observed for RacL11. Production ofcompared to that of RacH was probably due to a reduced
the respective viruses at the permissive and nonpermis-number of repeated elements downstream of the IR5
sive temperatures on EEL cells gave identical results ingene which has been reported earlier (Osterrieder et al.,
that virus titers of RacL11, HIR6-1, and HIR6-2 were re-
1996a). To ensure the RacH genomic backbone of the
duced up to 11.9-fold at 407, whereas RacH titers were
engineered IR6-recombinant viruses, viral DNA was ana-
reduced by 5250- to 9500-fold at the elevated tempera-lyzed by Southern blotting using the labeled PstI-frag-
ture (data not shown). From these results it was con-ment, which is contained in p06 and which represents
cluded that the absence and also the mutation of theEHV-1 gB-encoding sequences (Whalley et al., 1989;
wild-type IR6 protein expressed by RacM36 (OsterriederOsterrieder et al., 1995). Due to the absence of a SalI-
et al., 1996a) is associated with a temperature-sensitivitysite within the gB in RacH when compared to RacL11
of the Rac viruses at 407. Further, the insertion of one(Hu¨bert et al., 1996), the two viruses are readily distin-
copy of the wild-type IR6 gene into the RacH strain ledguishable from each other. The detection of a 12.3-kbp
to an enhancement of virus growth at 407 by more than
SalI-fragment in the digests of RacH, HIR6-1, and
300-fold.
HIR6-2 DNAs clearly demonstrated that the genomic
Examination of the production of viral proteins andbackbone of the generated viruses was that of RacH. In
release of virions at the permissive andRacL11 viral DNA, SalI-fragments of 9.7 and 2.6 kbp re-
nonpermissive temperatureacted with labeled p06, confirming the wild-type geno-
type of this plaque isolate (Fig. 2). As shown by indirect The next experiments were conducted to further char-
acterize the growth of the Rac plaque-isolates and theIF, both engineered viruses expressed the IR6 protein
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FIG. 3. Photographs of cells infected with wild-type RacL11, RacM36, RacH, or the recombinant virus HIR6-1 and analyzed by indirect immunofluo-
rescence using a monospecific anti-IR6 antiserum (O’Callaghan et al., 1994).
IR6-recombinant RacH viruses at different temperatures. did not exhibit major differences when incubated at 37
or 407, and comparable numbers of cells specificallyTo investigate the production of late viral proteins, mono-
layers of Edmin337 cells were infected with RacL11, stained with each of the antibodies and also exhibited
comparable signal intensities at both incubation temper-RacH, or the IR6-recombinant viruses HIR6-1 and
HIR6-2 (m.o.i.  1; see above) and incubated at either atures (Table 2). From these experiments, it was con-
cluded that the number of cells infected by RacH at the37 or 407. Cells were harvested at 24 hr p.i. and analyzed
by indirect immunofluorescence and flow cytometry. elevated temperature was comparable to that for each
of the other EHV-1 isolates. In addition, the productionComparable numbers of cells with comparable signal
intensities were reactive in RacL11-infected cell prepara- of the late gene products gB and gM, as reflected by the
signal intensities and numbers of infected cells, whichtions irrespective of the incubation temperature after
staining with the anti-gB mabs 4B6 and Be/3F8 (Huemer were determined by indirect immunofluorescence and
flow cytometry, was only marginally reduced in RacH-et al., 1995; Osterrieder et al., 1995, 1996b), or with the
anti-gM mab 13B2 (Allen and Yeargan, 1987; Osterrieder infected cells at 407 as compared to 377. Thus, the re-
duced production of infectious RacH virus progeny at 407et al., 1996b) (Table 2). A similar pattern of reactivity was
observed after immunological staining of cells infected was not due to a reduced number of infected cells or to
a failure in late gene expression.with RacH at both 37 or 407 (Table 2); i.e., both the ob-
served number of infected cells and also the signal inten- To investigate the numbers of virus particles released
into the supernatant of infected cells after infection withsities did not exhibit marked differences after incubation
at 37 or 407. Likewise, HIR6-1- or HIR6-2-infected cells the different viruses at 37 or 407, Edmin337 seeded in 6-
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TABLE 1 type IR6 protein therefore appears to be involved in a
late step in virus maturation or the release of infectiousSingle Step Growth of Rac Plaque Isolates and HIR6-1
virions as demonstrated by the reduction of physical andat 37 and 407a
infectious virus particles in supernatants of RacH-in-
Expt Ratio of virus titers fected cells at the nonpermissive temperature.
numberb 377 407 377/407
Virulence of HIR6-1 and HIR6-2 for mice
RacL11 1 2.4 1 106 4.6 1 105 5.2
2 8.7 1 105 3.3 1 105 2.6 The above experiments had shown that the IR6 protein
RacM36 1 2.1 1 106 1.2 1 104 175 influences the ability of EHV-1 to replicate at 407, al-
2 8.0 1 105 3.2 1 103 250
though the IR6 protein is nonessential for viral growthRacH 1 1.8 1 106 2.4 1 102 7,500
(Osterrieder et al., 1996a). To analyze the influence of2 7.3 1 105 2.0 1 102 3,650
HIR6-1 1 1.4 1 106 9.4 1 104 14.8 wild-type and mutated IR6 proteins on EHV-1 virulence,
2 8.9 1 105 6.2 1 104 14.4 experiments in a murine model (Awan et al., 1990) were
HIR6-2 1 4.4 1 106 3.9 1 105 11.3 performed. Mice were infected intranasally with 105 PFU
2 3.1 1 106 3.7 1 105 8.4
per mouse with EHV-1 strain RacL11 or the IR6-recombi-
nant viruses HIR6-1 and HIR6-2, and with 5 1 106 PFU pera Edmin337 cells were infected with 1 PFU per cell and incubated
at the indicated tepmerature. Virus progeny was harvested at 24 hr p.i., mouse of RacM36 and RacH. The results of the infection
titrated on Edmin337 cells, and incubated at 377 for 5 days. Production experiments (Figs. 4 and 5) can be summarized as fol-
of virus progeny on EEL cells and titration on Edmin337 cells gave lows: (i) RacM36- and RacH-infected mice did not exhibit
similar results.
any weight loss on Days 1 to 8 after infection but gainedb Results of two independent experiments are given.
body weight from Day 4 p.i. as did mock-infected mice
(data not shown). (ii) In contrast, a highly significant re-
well plates were infected with RacL11, RacH, HIR6-1, or duction of mean body weight (P¡ 0.001), as determined
HIR6-2 at an m.o.i. 1. The infected cells were incubated by pairwise testing according to Bonferroni (Holm, 1979),
at the respective temperatures, and supernatants (1 ml) was observed from Days 2 to 5 p.i. in mice infected with
were harvested at 24 hr p.i. The cell culture supernatants either RacL11 or the IR6-recombinant viruses HIR6-1 and
were cleared of cellular debris, virions were partially puri- HIR6-2. (iii) In the mouse groups infected with RacL11 or
fied by ultracentrifugation over a 30% sucrose cushion, the IR6-recombinant viruses, some animals also exhib-
and physical particles were counted in an electron micro- ited signs typical of EHV-1 infection, such as ruffled fur
scope. The results of these experiments are summarized and dyspnea, from Day 2 p.i. (iv) Virus titers of lungs of
in Table 3. In RacL11-infected cells, the numbers of phys-
ical particles present in infected-cell supernatants were
TABLE 2similar irrespective of the incubation temperature, and
60 to 84% of the counted viruses in each case contained Number of Infected Cells at 377 and 407 as Determined by Indirect
viral envelopes. The results obtained for HIR6-1 or HIR6- Immunofluorescence and FACscan Analysisa
2 closely paralleled those obtained for RacL11, inasmuch
377 407as the physical particle counts were approximately the
same at both incubation temperatures (Table 3). When
Percentage Percentage Ratio of
the number of physical virus particles was counted after Expt of positive of positive infected cells
infection of cells with RacH at 377, no major differences number cellsb cells 377/407
were seen as compared to RacL11, HIR6-1, or HIR6-2.
RacL11 1 76 71 1.1In contrast, the number of virus particles recovered after
2 56 42 1.3incubation of RacH-infected cells at 407 was drastically
RacH 1 67 60 1.1
reduced, such that a 15-fold or greater reduction in the 2 44 41 1.1
number of physical particles was observed as compared HIR6-1 1 71 61 1.2
2 49 43 1.1to 377. In addition, the overwhelming majority of observed
HIR6-2 1 67 59 1.1particles (90%) produced at 407 were nonenveloped
2 52 44 1.2(Table 3). From these results, it is concluded that (i) the
Mock 1 0.7 0.8
insertion of wild-type IR6 gene into the RacH genome 2 0.6 0.9
abolished the temperature-sensitive phenotype of RacH
a Immunofluorescence analyses were performed with anti-gB mabsin cell culture and led to the production of similar
4B6, Be/3F8, and anti-gM mab 13B2. Shown are the results for mabamounts of infectious virus at 37 and 407; (ii) The lack
4B6 of two independent experiments. Virtually identical results wereof production of infectious RacH virus progeny at the
obtained with the other mabs.
nonpermissive temperature was not due to a failure in b The number of gB-positive cells was determined relative to mock-
late gene expression as judged by the production of the infected cells. All signals beyond the FL1’s 98.5% percentile of mock-
infected cells were judged positive.representative late proteins gB and gM; (iii) The wild-
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TABLE 3
Number of Virus Particles Released in the Cell Culture Supernatanta
377 407
Expt Total Enveloped Percentage of Total Enveloped Percentage of Ratio of particles
numberb particles particles enveloped particles particles particles enveloped particles 377/407
RacL11 1 512 399 78 298 189 63 1.7
2 758 622 82 334 266 80 2.3
RacH 1 824 691 84 49 4 8 16.8
2 510 331 65 33 3 9 15.5
HIR6-1 1 424 314 74 323 246 76 1.3
2 781 532 68 491 378 77 1.6
HIR6-2 1 487 352 72 303 183 60 1.6
2 721 598 83 543 413 76 1.3
a Edmin337 cells were infected with 1 PFU per cell and incubated at the indicated temperatures for 24 hr. Virus particles were harvested by
ultracentrifugation and counted after negative staining in an electron microscope.
b Results of two independent experiments each are given. Numbers indicate particles per 10 randomly chosen grid sections.
individual mice necropsied on Days 1, 3, 5, and 8 paral- RacH virus restored the virulence of the avirulent parental
RacH virus since, as assayed by the criteria of bodyleled the observed loss of body weights. Virus titers in
lungs of mice infected with the avirulent Rac-derivatives weight loss, virus titers in mouse lungs, and viremia, the
HIR6-1 and HIR6-2 viruses were indistinguishable from(RacM36 and RacH) were reduced between 25- to 100-
fold on Day 1 p.i. when compared to lung titers of wild-type RacL11 virus.
RacL11-, HIR6-1-, and HIR6-2-infected mice, even though
a 50-fold higher dose of virus was employed for mice DISCUSSION
challenged with RacM36 or RacH. A similar reduction in
mean virus titers in the lung was also seen on the follow- The present study addressed the characterization of
the involvement of the IR6 (ORF67) gene product ining days p.i. On Day 8 p.i., no virus could be recovered
from lungs of RacH- or RacM36-infected mice (Fig. 5). EHV-1 virulence since previous observations had sug-
gested that the mutation or loss of the IR6 gene corre-(v) On Day 3 after infection, blood samples obtained by
cardiac puncture were analyzed for the presence of infec- lated with the avirulence of different plaque-isolates of
the EHV-1 strain Rac (Mayr et al., 1968; Hu¨bert et al.,tious viruses by cocultivation on Edmin337 cells. No vire-
mia was detected in RacH- or RacM36-infected mice, 1996; Osterrieder et al., 1996a). To investigate the possi-
ble involvement of the IR6 gene and protein in EHV-1whereas infectious virus could be recovered from
RacL11- as well as HIR6-1- and HIR6-2-infected mice virulence, IR6-recombinant RacH viruses were engi-
neered. Analysis of the genomes of the recombinant vi-(data not shown). From these results, we conclude that
the insertion of one copy of the wild-type IR6 gene into ruses, HIR6-1 and HIR6-2, revealed that one copy of the
FIG. 4. Mean body weights (in percentage) of mice infected with RacL11, RacM36, RacH, or the IR6-recombinant viruses HIR6-1 and HIR6-2,
respectively. Individual weights of mice were recorded at the time of infection and on Days 1 to 8 after infection. The weight of the individual mice
on Day 0 (time of infection) was set to 100%. There was a decreasing number of mice weighed from Day 1 (10 mice), Day 2/3 (8 mice), Days 4/5
(6 mice), to Days 6/7/8 (3 mice). Standard deviations (SD) ranged from 1.9 to 4.9%, and maximal SDs are indicated for each virus in parentheses.
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FIG. 5. Mean virus titers of lungs of two (Days 1, 8) or three (Days 3, 5) individual mice examined on Days 1, 3, 5, and 8 after test infection as
described in Fig. 4. Bars indicate standard deviations. The detection limit was 101 PFU per organ, and the cases where no virus from lungs was
recovered are indicated by 1. Asterisks indicate that differences in means of viral titers were significant (P ¡ 0.05) as determined by pairwise
testing according to Bonferroni after analysis of variance (Holm, 1979).
wild-type IR6 gene was inserted into the genome of both replication of the MLV RacH is greatly reduced at 407,
elevated body temperatures as observed in horses uponviruses. The fact that both recombinant viruses could be
propagated repeatedly without duplication or loss of the immunization with live RacH virus (Mayr et al., 1968)
might contribute to the avirulence of the vaccine strain.IR6 gene (Osterrieder et al., unpublished) indicated that
the asymmetric arrangement of the inverted repeat re- The IR6 protein is also a crucial determinant of
EHV-1 virulence as demonstrated by the conversion ofgions in EHV-1 might be more stable than that observed
for other Alphaherpesvirinae and confirmed previous ob- the apathogenic RacH virus to a highly virulent form by
insertion of a wild-type IR6 gene. The results obtainedservations for strain RacM36 (Hu¨bert et al., 1996). How-
ever, the insertion of one copy of the wild-type IR6-gene by testing the pathogenicity of individual EHV-1 strains
using the mouse model have proved to correlate wellin the modified live vaccine strain RacH was sufficient
to confer properties to the recombinant viruses that were with the behavior of EHV-1 strains in the natural host
(Slater et al., 1993; Inazu et al., 1993; vanWoensel et al.,indistinguishable from those of wild-type RacL11 virus.
These properties included the ability of the recombinant 1995; Hu¨bert et al., 1996; Colle et al., 1996; Matsumura
et al., 1996), but future experiments will nonethelessviruses to produce comparable amounts of infectious
virus progeny and numbers of physical virus particles address the pathogenic potential of the IR6-recombi-
nant RacH viruses in horses. As deduced from the nu-when incubated at either 37 or 407. These results empha-
sized the important role of the wild-type IR6 gene product cleotide sequence of the shortened RacH BamHI-N
fragment, not only the IR6 gene (ORF 67) but also thein the life cycle of EHV-1 and in the production of infec-
tious virus progeny. 25 carboxy-terminal amino acids of gene EUS1 (ORF
68) are deleted in the RacH genome and replaced bySince the production of proteins gB and gM, which are
representative of the late (g) class (Allen and Yeargan, 23 missense amino acids (Breeden et al., 1992; Telford
et al., 1992; Hu¨bert et al., 1996). However, RacM24 and1987; Sullivan et al., 1989; Osterrieder et al., 1996b), was
not reduced in RacH-infected cells at 407, but that the RacM36 do not exhibit any difference in the EUS1 gene
as compared to the wild-type RacL11 sequence and arenumber of both physical and infectious virus particles
was drastically reduced at the elevated temperature, it avirulent for both the natural host and laboratory ani-
mals (Mayr et al., 1968; Hu¨bert et al., 1996). These ob-is possible that the IR6 gene product modulates a very
late step in EHV-1 replication such as virus maturation servations and the facts that a single amino acid substi-
tution in the IR6 proteins of RacM24 and RacM36 isor egress. In addition, the overwhelming majority of de-
tected virus particles after infection with RacH at 407 responsible for the failure to form the rod-like structures
(Osterrieder et al., 1996a) and that these viruses exhibitrepresented nonenveloped particles which exhibited a
decreased stability under the preparative conditions for an avirulent phenotype might suggest that not only the
production of the IR6 protein but also its aggregationelectron microscopy (data not shown). One might specu-
late that one of the mechanisms of EHV-1 virulence is to to the rod-like structures is a salient feature of EHV-1
infection of cultured cells and may play a role in the inefficiently replicate at elevated temperatures in vivo, i.e.,
to perpetuate virus replication in febrile animals. Since vivo pathogenesis. The above facts are consistent with
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(1995). gp13 (EHV-gC): a complement receptor induced by equinethe findings that both RacM24 (data not shown) and
herpesviruses. Virus Res. 37, 113– 126.RacM36 also showed a significant reduction in virus
Inazu, M., Tsuha, O., Kirisawa, R., Kawakami, Y., and Iwai, H. (1993).
titers when propagated at 407. Equid herpesvirus infection in mice. J. Vet. Med. Sci. 55, 119 – 121.
Recently, the IR6 protein was shown to associate with Matsumura, T., O’Callaghan, D. J., Kondo, T., and Kamada, M. (1996).
Lack of virulence of the murine fibroblast adapted strain, Kentuckythe EHV-1 protein kinase (EUS2), and this association
A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses. Vet.was dependent on the ability of the IR6 protein to form the
Microbiol. 48, 353– 365.rod-like structures (Colle and O’Callaghan, 1996). Future
Mayr, A., Pette, J., Petzoldt, K., and Wagener, K. (1968). Untersuchungen
experiments will be performed to identify possible asso- zur Entwicklung eines Lebendimpfstoffes gegen die Rhinopneumon-
ciation(s) of the IR6 protein with cellular proteins and will itis (Stutenabort) der Pferde. J. Vet. Med. B. 15, 406– 418.
Meyer, H., Hu¨bert, P., Schwend, C., and Eichhorn, W. (1992). Rapidaddress the exact roles of the EHV-1 IR6 protein in the
identification of the vaccine strain RacH from EHV 1 field isolateslife cycle of EHV-1. The definition of IR6 function would
using a non-radioactive DNA probe. Vet. Microbiol. 30, 13 –20.be of particular interest for the evaluation of the safety O’Callaghan, D. J., Gentry, G. A., and Randall, C. C. (1983). The equine
of the modified live vaccine strain RacH. herpesviruses. In ‘‘The Herpesviruses’’ (B. Roizman, Ed.), Vol. 2, Com-
prehensive Virology, Series 2, pp. 215– 318. Plenum, NY.
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